Forian, Inc. is a leader in RWD and RWE generation and has developed one of the largest, integrated, repositories of healthcare data in the US. CHRONOS, Forian’s RWD ecosystem, is a novel offering that brings together open claims, closed claims, and consumer data to maximize the strengths of each and meet research aims across the clinical and life sciences industry.
CHRONOS links patients across the following RWD sources:
Komodo Health is a healthcare technology company creating the new standard for real-world data and analytics through its platform, which enables real-time, accurate, and actionable insight into the treatment, diagnosis, costs, and outcomes journeys of millions of patients across the US.
Truveta is a leader in EHR data and analytics, led by a growing health system collective that together provide more than 17% of all daily clinical care in the US. Truveta is trusted by more than 40 leading healthcare and life science customers to improve patient care, accelerate R&D, and inform public policy. Across these leading organizations, Truveta connects data, people, and ideas to pursue a shared mission of saving lives with data.
OM1 is an insights-driven technology and data company specializing in Personalized Medicine, Evidence Generation, and RWE Research powered by next-gen A.I. platforms, regulatory-grade deep longitudinal data, and globally recognized thought leadership.
Our unprecedented innovation takes RWE from bench to practice, delivering unparalleled personalized impact on the outcomes of patients and the advancement of research.
We do things differently. We are pushing the boundaries of healthcare, reimagining how industry, providers, payers, and patients use real-world evidence. We are globally recognized for the integration of cutting-edge AI and data technologies. As pioneers in the field, our commitment to leveraging technology propels healthcare transformation, enhancing patient outcomes and setting new industry benchmarks.
Prognos Health is the most trusted real-world data provider that unlocks the power of data to improve health. Prognos is accelerating the development and delivery of innovative therapies and improving health outcomes by offering fully integrated and harmonized lab and health records on more than 325 million de-identified patients. Prognos Health's platform provides a comprehensive, integrated view of patient health, enabling life sciences companies to make better decisions about care. Learn more at prognoshealth.com.
Magnolia Market Access provides tailored strategies and insights to pharmaceutical companies, device manufacturers, and trade associations meeting their market access, HEOR, and healthcare policy needs. Our experts provide 360-degree perspectives and analysis of our in-house and client specific clinical and real-world data to shape policy, communicate value, secure reimbursement, and drive patient access. Magnolia Market Access works with you to maximize access from the earliest stages of development through patent expiration and beyond.
Flatiron Health is a healthtech company expanding the possibilities for point of care solutions in oncology and using data for good to power smarter care for every person with cancer. Through machine learning and AI, real-world evidence, and breakthroughs in clinical trials, we continue to transform patients’ real-life experiences into knowledge and create a more modern, connected oncology ecosystem. Flatiron Health is an independent affiliate of the Roche Group. Flatiron.com @FlatironHealth.
EVERSANA™ is the leading provider of global commercial services to the life sciences industry. Our integrated solutions are rooted in the patient experience and span all stages of the product life cycle to deliver long-term, sustainable value for patients, prescribers, channel partners and payers. We serve more than 500 organizations, including innovative start-ups and established pharmaceutical companies to advance life science solutions for a healthier world. To learn more about EVERSANA, visit eversana.com.
Adelphi Real World: Experts in generating real-world data and shaping real-world evidence
Conducting multi-country real-world observational studies for over 25 years, grounded in extensive heritage of Adelphi’s Disease Specific Programmes™, supported by the expansion of our real-world evidence services to meet pharmaceutical client needs.
We provide a unique range of real-world data involving physicians, patients, and caregivers; achieved through our market-leading Disease Specific Programmes™, tailored non-interventional studies, international secondary database analyses and evidence landscaping.
Top pharma, payers, and government agencies partner with HealthVerity to solve their most complicated use cases through transformative technologies and real-world data (RWD) infrastructure. The HealthVerity IPGE platform, based on the foundational elements of Identity, Privacy, Governance, and Exchange, enables the discovery of RWD across the broadest healthcare data ecosystem, the building of more complete patient journeys and the ability to power next-gen analytics and applications.
